4//SEC Filing
Moore Matthew Richard 4
Accession 0001787306-23-000092
CIK 0001787306other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 7:39 AM ET
Size
5.6 KB
Accession
0001787306-23-000092
Insider Transaction Report
Form 4
Moore Matthew Richard
SVP and Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-29+12,500→ 12,500 totalExercise: $28.72Exp: 2031-01-18→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]1/48th of the shares vest on each monthly anniversary of the milestone vesting commencement date, beginning on September 29, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001840191
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 7:39 AM ET
- Size
- 5.6 KB